Summit Trail Advisors’s Elanco Animal Health ELAN Stock Holding History

Summit Trail Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Sell	108,576 -1,143	-1%	-$26.4K	0.03%	421
2026 Q1	$2.63M	Buy	109,719 +10,048	+10%	+$246K	0.04%	369
2025 Q4	$2.26M	Buy	99,671 +16,129	+19%	+$351K	0.04%	339
2025 Q3	$1.68M	Buy	83,542 +39,407	+89%	+$660K	0.02%	538
2025 Q2	$630K	Buy	+44,135	New	+$516K	0.01%	643
2025 Q1	–	Sell	-16,428	Closed	-$199K	–	435
2024 Q4	$199K	Buy	+16,428	New	+$215K	0.01%	359

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Summit Trail Advisors's ELAN Position: Q2 2026 in Review

Summit Trail Advisors reduced its Elanco Animal Health (ELAN) stake by 1% in Q2 2026, selling an estimated $26.4K and leaving 108,576 shares worth $2.67M. The position accounts for 0.03% of the portfolio, ranked #421.

Summit Trail Advisors first reported a position in ELAN in Q4 2024 and has held it in 6 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Summit Trail Advisors held 108,576 shares of Elanco Animal Health worth $2.67M as of Q2 2026.
Summit Trail Advisors sold 1,143 Elanco Animal Health shares in Q2 2026, an estimated $26.4K.
Elanco Animal Health made up 0.03% of Summit Trail Advisors's portfolio in Q2 2026, its #421 holding.
Summit Trail Advisors first reported a position in Elanco Animal Health in Q4 2024 and has held it in 6 quarters since.
522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.